1. Denmark Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: major
Novo Nordisk A/S Class B

Novo Nordisk A/S Class B

285.20
DKK
+15.05
(+5.57%)
26.20EPS
11.99P/E
1.39TMarket Cap
Feb 03Next Earn

Novo Nordisk A/S Class B Documents

Q3 FY2025 · Interim report

Novo Nordisk - Q3 2025 - Interim Report · November 5, 2025 · 38 pages

Read Novo Nordisk A/S Class B's results firsthand

Preview the first 2 pages of this interim report
Create a free account to start reading

Full documents are included with Professional

Q3 FY2025 documents

Interim report

Novo Nordisk - Q3 2025 - Interim Report

38 pages

Nov 5, 2025

Interim report

38 pages

Nov 5, 2025

Presentation

Q3-2025-investor-presentation (1)

138 pages

Presentation

20251009_Akero_conf_call_slides (2)

8 pages

Presentation

12 pages

Presentation

138 pages

Press release

ca251021-egm1 (1)

2 pages

Oct 21, 2025

Press release

5 pages

Oct 9, 2025

Q3 FY2025 earnings call →